Jose M. Irimia, et.al., Impaired glucose tolerance and predisposition to the fasted state in liver glycogen synthase knock-out mice., The Journal of biological chemistry, 2010, 285

http://rdf.ncbi.nlm.nih.gov/pubmed/20178984

Jose M. Irimia, et.al., Impaired glucose tolerance and predisposition to the fasted state in liver glycogen synthase knock-out mice., The Journal of biological chemistry, 2010, 285

http://rdf.ncbi.nlm.nih.gov/pubmed/

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD20830
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD20830

allele

http://purl.org/net/cito/citesAsAuthority

• Gys2<tm1.1Pro>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4462836

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased liver triglyceride level_Gys2<tm1.1Pro>/Gys2<tm1.1Pro>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0009355I129S6SvEvTacC57BL6C57BL6JDBAGys2tm11ProGys2tm11ProTgAlbcre21Mgn0TgAlbcre21MgnGys2tm11Pro
• abnormal gluconeogenesis_Gys2<tm1.1Pro>/Gys2<tm1.1Pro>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0003383I129S6SvEvTacC57BL6C57BL6JDBAGys2tm11ProGys2tm11ProTgAlbcre21Mgn0TgAlbcre21MgnGys2tm11Pro
• decreased circulating insulin level_Gys2<tm1.1Pro>/Gys2<tm1.1Pro>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0002727I129S6SvEvTacC57BL6C57BL6JDBAGys2tm11ProGys2tm11ProTgAlbcre21Mgn0TgAlbcre21MgnGys2tm11Pro
• decreased heart weight_Gys2<tm1.1Pro>/Gys2<tm1.1Pro>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0002834I129S6SvEvTacC57BL6C57BL6JDBAGys2tm11ProGys2tm11ProTgAlbcre21Mgn0TgAlbcre21MgnGys2tm11Pro
• decreased circulating glucose level_Gys2<tm1.1Pro>/Gys2<tm1.1Pro>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0005560I129S6SvEvTacC57BL6C57BL6JDBAGys2tm11ProGys2tm11ProTgAlbcre21Mgn0TgAlbcre21MgnGys2tm11Pro
• decreased systemic arterial diastolic blood pressure_Gys2<tm1.1Pro>/Gys2<tm1.1Pro>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0006263I129S6SvEvTacC57BL6C57BL6JDBAGys2tm11ProGys2tm11ProTgAlbcre21Mgn0TgAlbcre21MgnGys2tm11Pro
• decreased glycogen level_Gys2<tm1.1Pro>/Gys2<tm1.1Pro>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0005439I129S6SvEvTacC57BL6C57BL6JDBAGys2tm11ProGys2tm11ProTgAlbcre21Mgn0TgAlbcre21MgnGys2tm11Pro
• impaired exercise endurance_Gys2<tm1.1Pro>/Gys2<tm1.1Pro>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0012106I129S6SvEvTacC57BL6C57BL6JDBAGys2tm11ProGys2tm11ProTgAlbcre21Mgn0TgAlbcre21MgnGys2tm11Pro
• abnormal triglyceride level_Gys2<tm1.1Pro>/Gys2<tm1.1Pro>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0000187I129S6SvEvTacC57BL6C57BL6JDBAGys2tm11ProGys2tm11ProTgAlbcre21Mgn0TgAlbcre21MgnGys2tm11Pro
• decreased glycogen catabolism rate_Gys2<tm1.1Pro>/Gys2<tm1.1Pro>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0002715I129S6SvEvTacC57BL6C57BL6JDBAGys2tm11ProGys2tm11ProTgAlbcre21Mgn0TgAlbcre21MgnGys2tm11Pro
• decreased liver weight_Gys2<tm1.1Pro>/Gys2<tm1.1Pro>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0003402I129S6SvEvTacC57BL6C57BL6JDBAGys2tm11ProGys2tm11ProTgAlbcre21Mgn0TgAlbcre21MgnGys2tm11Pro
• impaired glucose tolerance_Gys2<tm1.1Pro>/Gys2<tm1.1Pro>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0005293I129S6SvEvTacC57BL6C57BL6JDBAGys2tm11ProGys2tm11ProTgAlbcre21Mgn0TgAlbcre21MgnGys2tm11Pro
• abnormal glucose homeostasis_Gys2<tm1.1Pro>/Gys2<tm1.1Pro>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0002078I129S6SvEvTacC57BL6C57BL6JDBAGys2tm11ProGys2tm11ProTgAlbcre21Mgn0TgAlbcre21MgnGys2tm11Pro
• decreased cardiac cell glucose uptake_Gys2<tm1.1Pro>/Gys2<tm1.1Pro>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0030020I129S6SvEvTacC57BL6C57BL6JDBAGys2tm11ProGys2tm11ProTgAlbcre21Mgn0TgAlbcre21MgnGys2tm11Pro
• abnormal circulating ketone body level_Gys2<tm1.1Pro>/Gys2<tm1.1Pro>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0003457I129S6SvEvTacC57BL6C57BL6JDBAGys2tm11ProGys2tm11ProTgAlbcre21Mgn0TgAlbcre21MgnGys2tm11Pro